Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill

B. Sadurska, M. T. Tacconi, G. Di Minno, M. C. Roncaglioni, J. Pangrazzi, M. B. Donati, A. Bizzi, M. J. Silver

Research output: Contribution to journalArticle

Abstract

Sensitivity to induction of platelet aggregation by arachidonic acid (AA) and changes in plasma and platelet polyunsaturated fatty acid distribution were studied in seven women before and after six months of oral contraceptive (OC) treatment with a combination of d-norgestrel (0.25 mg) and ethinylestradiol (0.05 mg). Special interest was focused on AA because certain metabolites of this fatty acid induce platelets to aggregate and are considered to play a crucial role in thromboembolic processes. In plasma, AA concentrations increased slightly, but significantly, in both the free fatty acid (FFA) and phospholipid fraction; in platelets AA increased in the phospholipid and neutral lipid fractions. The threshold aggregating concentration (TAC) of AA was significantly reduced in platelets of women after six months of OC treatment (0.65 ± 0.08 versus 0.30 ± 0.04 mM). This suggests that changes in platelet fatty acid composition may be associated with in vitro changes in platelet sensitivity to AA. Such changes may contribute to the thrombotic tendency associated with OC treatment.

Original languageEnglish
Pages (from-to)150-153
Number of pages4
JournalThrombosis and Haemostasis
Volume45
Issue number2
Publication statusPublished - 1981

Fingerprint

Platelet Aggregation
Arachidonic Acid
Blood Platelets
Lipids
Oral Contraceptives
Phospholipids
Fatty Acids
Norgestrel
Ethinyl Estradiol
Unsaturated Fatty Acids
Nonesterified Fatty Acids
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill. / Sadurska, B.; Tacconi, M. T.; Di Minno, G.; Roncaglioni, M. C.; Pangrazzi, J.; Donati, M. B.; Bizzi, A.; Silver, M. J.

In: Thrombosis and Haemostasis, Vol. 45, No. 2, 1981, p. 150-153.

Research output: Contribution to journalArticle

Sadurska, B, Tacconi, MT, Di Minno, G, Roncaglioni, MC, Pangrazzi, J, Donati, MB, Bizzi, A & Silver, MJ 1981, 'Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill', Thrombosis and Haemostasis, vol. 45, no. 2, pp. 150-153.
Sadurska, B. ; Tacconi, M. T. ; Di Minno, G. ; Roncaglioni, M. C. ; Pangrazzi, J. ; Donati, M. B. ; Bizzi, A. ; Silver, M. J. / Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill. In: Thrombosis and Haemostasis. 1981 ; Vol. 45, No. 2. pp. 150-153.
@article{ed634fa4a0644a6cbb368059c8917ecc,
title = "Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill",
abstract = "Sensitivity to induction of platelet aggregation by arachidonic acid (AA) and changes in plasma and platelet polyunsaturated fatty acid distribution were studied in seven women before and after six months of oral contraceptive (OC) treatment with a combination of d-norgestrel (0.25 mg) and ethinylestradiol (0.05 mg). Special interest was focused on AA because certain metabolites of this fatty acid induce platelets to aggregate and are considered to play a crucial role in thromboembolic processes. In plasma, AA concentrations increased slightly, but significantly, in both the free fatty acid (FFA) and phospholipid fraction; in platelets AA increased in the phospholipid and neutral lipid fractions. The threshold aggregating concentration (TAC) of AA was significantly reduced in platelets of women after six months of OC treatment (0.65 ± 0.08 versus 0.30 ± 0.04 mM). This suggests that changes in platelet fatty acid composition may be associated with in vitro changes in platelet sensitivity to AA. Such changes may contribute to the thrombotic tendency associated with OC treatment.",
author = "B. Sadurska and Tacconi, {M. T.} and {Di Minno}, G. and Roncaglioni, {M. C.} and J. Pangrazzi and Donati, {M. B.} and A. Bizzi and Silver, {M. J.}",
year = "1981",
language = "English",
volume = "45",
pages = "150--153",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "2",

}

TY - JOUR

T1 - Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill

AU - Sadurska, B.

AU - Tacconi, M. T.

AU - Di Minno, G.

AU - Roncaglioni, M. C.

AU - Pangrazzi, J.

AU - Donati, M. B.

AU - Bizzi, A.

AU - Silver, M. J.

PY - 1981

Y1 - 1981

N2 - Sensitivity to induction of platelet aggregation by arachidonic acid (AA) and changes in plasma and platelet polyunsaturated fatty acid distribution were studied in seven women before and after six months of oral contraceptive (OC) treatment with a combination of d-norgestrel (0.25 mg) and ethinylestradiol (0.05 mg). Special interest was focused on AA because certain metabolites of this fatty acid induce platelets to aggregate and are considered to play a crucial role in thromboembolic processes. In plasma, AA concentrations increased slightly, but significantly, in both the free fatty acid (FFA) and phospholipid fraction; in platelets AA increased in the phospholipid and neutral lipid fractions. The threshold aggregating concentration (TAC) of AA was significantly reduced in platelets of women after six months of OC treatment (0.65 ± 0.08 versus 0.30 ± 0.04 mM). This suggests that changes in platelet fatty acid composition may be associated with in vitro changes in platelet sensitivity to AA. Such changes may contribute to the thrombotic tendency associated with OC treatment.

AB - Sensitivity to induction of platelet aggregation by arachidonic acid (AA) and changes in plasma and platelet polyunsaturated fatty acid distribution were studied in seven women before and after six months of oral contraceptive (OC) treatment with a combination of d-norgestrel (0.25 mg) and ethinylestradiol (0.05 mg). Special interest was focused on AA because certain metabolites of this fatty acid induce platelets to aggregate and are considered to play a crucial role in thromboembolic processes. In plasma, AA concentrations increased slightly, but significantly, in both the free fatty acid (FFA) and phospholipid fraction; in platelets AA increased in the phospholipid and neutral lipid fractions. The threshold aggregating concentration (TAC) of AA was significantly reduced in platelets of women after six months of OC treatment (0.65 ± 0.08 versus 0.30 ± 0.04 mM). This suggests that changes in platelet fatty acid composition may be associated with in vitro changes in platelet sensitivity to AA. Such changes may contribute to the thrombotic tendency associated with OC treatment.

UR - http://www.scopus.com/inward/record.url?scp=0019430416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019430416&partnerID=8YFLogxK

M3 - Article

C2 - 7256698

AN - SCOPUS:0019430416

VL - 45

SP - 150

EP - 153

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -